Wen-Jing Hsu

Wen-Jing Hsu

Auto-generated profile, based on publicly available information

Wen-Jing Hsu

Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei, Taiwan. 1

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 July 2024 in Cancer Research
Verified
Journal Article
Closed access
PDF file
WHWen-Jing Hsu
Wen-Jing Hsu
MCMing-Chen Chiang
Ming-Chen Chiang
YCYi-Chun Chao
Yi-Chun Chao
YCYu-Chu Chang
Yu-Chu Chang
MHMing-Chien Hsu
Ming-Chien Hsu
CLCheng-Wei Lin
Cheng-Wei Lin
Dysregulated mitochondrial dynamics and metabolism play important roles in tumorigenesis. Metastasizing tumor cells predominantly utilize mitochondrial metabolism, and regulators of metabolic reprogramming may provide reliable biomarkers for diagnosing cancer metastasis. Here, we identified a type I arginine methyltransferase–DEAD-box polypeptide 3, X-linked (PRMT1-DDX3) axis that promotes breast cancer metastasis by coordinating mitochondrial biogenesis and mitophagy to ensure mitochondrial quality control. Mechanistically, PRMT1 induces arginine methylation of DDX3, which enhances its protein stability and prevents proteasomal degradation. DDX3 mediates mitochondrial homeostasis by translocating to mitochondria where it facilitates phosphatase and tensin homology-induced kinase 1 translation in response to mitochondrial stress. Inhibition of DDX3 suppresses mitochondrial biogenesis and mitophagy, resulting in diminished cancer stemness and metastatic properties. Overall, this study uncovers a mechanism by which the PRMT1-DDX3 axis regulates mitochondrial homeostasis to support breast cancer metastasis, suggesting strategies for targeting metabolic vulnerabilities to treat metastatic breast cancer. Significance: DDX3 is stabilized by PRMT1–mediated arginine methylation and coordinates mitophagy and mitochondrial biogenesis by upregulating PINK1 to facilitate breast cancer progression.

17 June 2026
Verified
Other
Open access
WHWen-Jing Hsu
Wen-Jing Hsu
MCMing-Chen Chiang
Ming-Chen Chiang
YCYi-Chun Chao
Yi-Chun Chao
YCYu-Chu Chang
Yu-Chu Chang
MHMing-Chien Hsu
Ming-Chien Hsu
CLCheng-Wei Lin
Cheng-Wei Lin
PRMT1-mediated DDX3 methylation contributes to recruitment of translation initiating factors, and DDX3 binds to PINK1 mRNA to promotes its translation.

17 June 2026
Verified
Other
Open access
PDF file
WHWen-Jing Hsu
Wen-Jing Hsu
MCMing-Chen Chiang
Ming-Chen Chiang
YCYi-Chun Chao
Yi-Chun Chao
YCYu-Chu Chang
Yu-Chu Chang
MHMing-Chien Hsu
Ming-Chien Hsu
CLCheng-Wei Lin
Cheng-Wei Lin
DDX3 regulates mitophagy in breast cancer.

17 June 2026
Verified
Other
Open access
WHWen-Jing Hsu
Wen-Jing Hsu
MCMing-Chen Chiang
Ming-Chen Chiang
YCYi-Chun Chao
Yi-Chun Chao
YCYu-Chu Chang
Yu-Chu Chang
MHMing-Chien Hsu
Ming-Chien Hsu
CLCheng-Wei Lin
Cheng-Wei Lin
PRMT1 is associated with oxidative phosphorylation (OXPHOS) in breast cancer.

16 September 2024
Verified
Other
Open access
WHWen-Jing Hsu
Wen-Jing Hsu
MCMing-Chen Chiang
Ming-Chen Chiang
YCYi-Chun Chao
Yi-Chun Chao
YCYu-Chu Chang
Yu-Chu Chang
MHMing-Chien Hsu
Ming-Chien Hsu
CLCheng-Wei Lin
Cheng-Wei Lin
Dysregulated mitochondrial dynamics and metabolism play important roles in tumorigenesis. Metastasizing tumor cells predominantly utilize mitochondrial metabolism, and regulators of metabolic reprogramming may provide reliable biomarkers for diagnosing cancer metastasis. Here, we identified a type I arginine methyltransferase–DEAD-box polypeptide 3, X-linked (PRMT1-DDX3) axis that promotes breast cancer metastasis by coordinating mitochondrial biogenesis and mitophagy to ensure mitochondrial quality control. Mechanistically, PRMT1 induces arginine methylation of DDX3, which enhances its protein stability and prevents proteasomal degradation. DDX3 mediates mitochondrial homeostasis by translocating to mitochondria where it facilitates phosphatase and tensin homology-induced kinase 1 translation in response to mitochondrial stress. Inhibition of DDX3 suppresses mitochondrial biogenesis and mitophagy, resulting in diminished cancer stemness and metastatic properties. Overall, this study uncovers a mechanism by which the PRMT1-DDX3 axis regulates mitochondrial homeostasis to support breast cancer metastasis, suggesting strategies for targeting metabolic vulnerabilities to treat metastatic breast cancer.Significance: DDX3 is stabilized by PRMT1–mediated arginine methylation and coordinates mitophagy and mitochondrial biogenesis by upregulating PINK1 to facilitate breast cancer progression.

17 June 2026
Verified
Other
Open access
WHWen-Jing Hsu
Wen-Jing Hsu
MCMing-Chen Chiang
Ming-Chen Chiang
YCYi-Chun Chao
Yi-Chun Chao
YCYu-Chu Chang
Yu-Chu Chang
MHMing-Chien Hsu
Ming-Chien Hsu
CLCheng-Wei Lin
Cheng-Wei Lin
Dysregulated mitochondrial dynamics and metabolism play important roles in tumorigenesis. Metastasizing tumor cells predominantly utilize mitochondrial metabolism, and regulators of metabolic reprogramming may provide reliable biomarkers for diagnosing cancer metastasis. Here, we identified a type I arginine methyltransferase–DEAD-box polypeptide 3, X-linked (PRMT1-DDX3) axis that promotes breast cancer metastasis by coordinating mitochondrial biogenesis and mitophagy to ensure mitochondrial quality control. Mechanistically, PRMT1 induces arginine methylation of DDX3, which enhances its protein stability and prevents proteasomal degradation. DDX3 mediates mitochondrial homeostasis by translocating to mitochondria where it facilitates phosphatase and tensin homology-induced kinase 1 translation in response to mitochondrial stress. Inhibition of DDX3 suppresses mitochondrial biogenesis and mitophagy, resulting in diminished cancer stemness and metastatic properties. Overall, this study uncovers a mechanism by which the PRMT1-DDX3 axis regulates mitochondrial homeostasis to support breast cancer metastasis, suggesting strategies for targeting metabolic vulnerabilities to treat metastatic breast cancer.Significance:DDX3 is stabilized by PRMT1–mediated arginine methylation and coordinates mitophagy and mitochondrial biogenesis by upregulating PINK1 to facilitate breast cancer progression.